MARKET

AMAG

AMAG

AMAG
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.60
+0.36
+4.97%
Opening 15:38 07/14 EDT
OPEN
7.27
PREV CLOSE
7.24
HIGH
7.66
LOW
7.10
VOLUME
279.88K
TURNOVER
--
52 WEEK HIGH
13.53
52 WEEK LOW
4.410
MARKET CAP
260.47M
P/E (TTM)
-0.6986
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMAG stock price target is 8.14 with a high estimate of 10.00 and a low estimate of 5.00.

EPS

AMAG News

More
AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis
GlobeNewswire · 2d ago
Hedge Funds Still Kind Of Bullish On AMAG Pharmaceuticals, Inc. (AMAG)
Insider Monkey · 07/06 15:00
Forensic Value Stock Analysis: Top Positive And Negative Scoring Stocks Mid-Year 2020
Seeking Alpha - Article · 07/06 09:44
Edited Transcript of AMAG earnings conference call or presentation 11-May-20 12:00pm GMT
Q1 2020 AMAG Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents · 06/11 17:55
AMAG Pharma's finance chief bids adieu
Seeking Alpha - Article · 06/11 12:17
AMAG Pharmaceuticals Announces Leadership Changes
GlobeNewswire · 06/11 12:00
AMAG Pharma Reports CFO, COO Ted Myles Leaving Co., Names Anthony Casciano COO, Senior VP Of Finance, Brian Piekos, Interim CFO; Has Initiated Succession Plan To Find Permanent Replacements
Benzinga · 06/11 11:04
Why Is AMAG Pharmaceuticals (AMAG) Up 6.8% Since Last Earnings Report?
AMAG Pharmaceuticals (AMAG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 06/10 15:30

Industry

Pharmaceuticals
+1.06%
Pharmaceuticals & Medical Research
+1.25%

Hot Stocks

Symbol
Price
%Change

About AMAG

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.
More

Webull offers kinds of AMAG Pharmaceuticals, Inc. stock information, including NASDAQ:AMAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMAG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMAG stock methods without spending real money on the virtual paper trading platform.